|1.||Rosenberg, Steven A: 5 articles (10/2009 - 08/2003)|
|2.||Restifo, Nicholas P: 3 articles (11/2005 - 08/2003)|
|3.||Wunderlich, John R: 2 articles (10/2009 - 08/2003)|
|4.||Hwu, Patrick: 2 articles (11/2006 - 08/2003)|
|5.||Parkhurst, Maria R: 2 articles (11/2006 - 03/2004)|
|6.||Rosenberg, S A: 2 articles (09/2000 - 06/2000)|
|7.||Vincelette, Nicole D: 1 article (01/2015)|
|8.||Mansour, Iyad: 1 article (01/2015)|
|9.||Hariri, Dana: 1 article (01/2015)|
|10.||Motamed, Sara: 1 article (01/2015)|
|1.||Melanoma (Melanoma, Malignant)
08/01/2003 - "Recombinant fowlpox viruses encoding the anchor-modified gp100 melanoma antigen can generate antitumor immune responses in patients with metastatic melanoma."
03/01/1994 - "Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes."
11/15/2005 - "Active-specific immunotherapy with dendritic cells loaded with peptide derived from the melanoma antigen, gp100, failed to mediate regression of established B16F10 melanoma in normal mice. "
03/15/2002 - "The ability to load irradiated tumor cells was reproduced in two analogous human melanoma models using melanoma cell lines expressing gp100 and CTL clones specific for a gp100 melanoma antigen. "
11/15/2009 - "To test this question, we treated B16 murine melanoma with the combination of the HDAC inhibitor LAQ824 and the adoptive transfer of gp100 melanoma antigen-specific pmel-1 T cells. "
04/01/2009 - "In this study, we showed the importance of antigen presentation via a major histocompatibility complex (MHC) class II molecule in cancer immunity against non-membrane bound TAAs such as the melanoma antigen gp100 by using DCs derived from MHC class II-deficient mice (C2KO). "
05/01/2011 - "We assessed the level of anti-tumor immunity conferred by this engineered lentivector encoding the melanoma antigen gp100 in a mouse model. "
02/15/2006 - "Enhanced viral and tumor immunity with intranodal injection of canary pox viruses expressing the melanoma antigen, gp100."
06/15/2000 - "Threshold levels of gene expression of the melanoma antigen gp100 correlate with tumor cell recognition by cytotoxic T lymphocytes."
06/15/1998 - "Genetic vaccination against the melanocyte lineage-specific antigen gp100 induces cytotoxic T lymphocyte-mediated tumor protection."
05/01/2002 - "In this study, Lptn and/or melanoma-associated antigen gp100 were transfected into mouse bone marrow-derived DC, which were used as vaccines in B16 melanoma model. "
09/01/2003 - "To improve the antitumor effect of DC vaccine, Th1-biasing cytokine interleukin (IL) 18 and melanoma-associated antigen gp100 were cotransfected into bone marrow-derived DC (IL-18/gp100-DC), which were used as vaccine to induce the protective and therapeutic immunity in a B16 melanoma model. "
|5.||B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
|5.||HLA-A2 Antigen (HLA A2 Antigen)
|6.||Monophenol Monooxygenase (Tyrosinase)
|7.||HLA-A Antigens (HLA-A)